CS and COVID-19: Consequently, in the context of COVID-19, C1-INH might mitigate uncontrolled CS activation and collateral lung damage, reduce capillary leakage and subsequent pulmonary edema, inhibit the generation of microthrombi via the KKS and CAS pathways, and preserve the regulatory role of endothelial cells.